Literature DB >> 3604947

Usefulness of echocardiographic evidence of pericardial effusion and mitral regurgitation during the acute stage in predicting development of coronary arterial aneurysms in the late stage of Kawasaki disease.

S S Gidding, C E Duffy, S Pajcic, K Berdusis, S T Shulman.   

Abstract

In 28 patients with Kawasaki disease, the relation of specific echocardiographic findings identified during the acute study of the illness, including valvular regurgitation, to development of coronary aneurysms was evaluated. Initial studies were performed at the time of clinical presentation, 5 to 10 days after the onset of fever, and follow-up studies were performed 1 to 2 months later. Patients in whom coronary aneurysms developed were more likely to have pericardial effusion (p = 0.0006) or mitral regurgitation (MR) (p = 0.014) at initial echocardiographic study than those without aneurysms. Presence of either mitral regurgitation (MR) or pericardial effusion had a positive predictive value of 0.84 for aneurysm development. Twenty-three percent of patients had MR, and it was associated with mild LV dilatation (35 +/- 3 vs 32 +/- 5 mm, p less than 0.05). Insufficiency of other valves was rare. Thus, MR and pericardial effusion on acute phase echocardiographic examination may predict development of coronary aneurysms in Kawasaki disease. Mild MR occurs frequently in acute Kawasaki disease and is associated with mild LV dilation.

Entities:  

Mesh:

Year:  1987        PMID: 3604947     DOI: 10.1016/0002-9149(87)90988-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease.

Authors:  Beth F Printz; Lynn A Sleeper; Jane W Newburger; L LuAnn Minich; Timothy Bradley; Meryl S Cohen; Deborah Frank; Jennifer S Li; Renee Margossian; Girish Shirali; Masato Takahashi; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

2.  Antibodies to native type III collagen in the serum of patients with Kawasaki disease.

Authors:  S Kobayashi; N Wada; M Kubo
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

3.  Plasma follistatin-like protein 1 is elevated in Kawasaki disease and may predict coronary artery aneurysm formation.

Authors:  Mark Gorelik; David C Wilson; Yona K Cloonan; Stanford T Shulman; Raphael Hirsch
Journal:  J Pediatr       Date:  2012-02-07       Impact factor: 4.406

4.  Kawasaki disease in an 8-day-old neonate.

Authors:  Naomi Nakagawa; Momo Yoshida; Kouji Narahara; Taiji Kunitomi
Journal:  Pediatr Cardiol       Date:  2008-12-20       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.